227 related articles for article (PubMed ID: 21464041)
21. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
22. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.
Yuan JM; Ambinder A; Fan Y; Gao YT; Yu MC; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):590-4. PubMed ID: 19190166
[TBL] [Abstract][Full Text] [Related]
24. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
25. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
[TBL] [Abstract][Full Text] [Related]
26. Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.
Cheng HY; Kang PJ; Chuang YH; Wang YH; Jan MC; Wu CF; Lin CL; Liu CJ; Liaw YF; Lin SM; Chen PJ; Lee SD; Yu MW
PLoS One; 2014; 9(11):e95870. PubMed ID: 25427199
[TBL] [Abstract][Full Text] [Related]
27. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.
Loomba R; Yang HI; Su J; Brenner D; Barrett-Connor E; Iloeje U; Chen CJ
Am J Epidemiol; 2013 Feb; 177(4):333-42. PubMed ID: 23355498
[TBL] [Abstract][Full Text] [Related]
28. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
30. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
[TBL] [Abstract][Full Text] [Related]
31. Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers.
Nien HC; Sheu JC; Kao JH; Chou HC; Su CW; Chen CH
J Med Virol; 2011 Aug; 83(8):1326-31. PubMed ID: 21678436
[TBL] [Abstract][Full Text] [Related]
32. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
33. Elevated serum insulin is an independent risk factor for hepatocellular carcinoma: a case control study from Nepal.
Gupta SP; Mittal A; Sathian B; Jha DK
Asian Pac J Cancer Prev; 2013; 14(12):7331-3. PubMed ID: 24460297
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
[TBL] [Abstract][Full Text] [Related]
35. The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China.
Tan Y; Zhang X; Zhang W; Tang L; Yang H; Yan K; Jiang L; Yang J; Li C; Yang J; Wen T; Tang H; Yan L
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2038-2046. PubMed ID: 31533942
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers.
Tang B; Kruger WD; Chen G; Shen F; Lin WY; Mboup S; London WT; Evans AA
J Med Virol; 2004 Jan; 72(1):35-40. PubMed ID: 14635008
[TBL] [Abstract][Full Text] [Related]
37. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
[TBL] [Abstract][Full Text] [Related]
38. PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.
Huang L; Mo Z; Lao X; Zhang X; Liu Y; Sui J; Qin X; Li S
Tumour Biol; 2016 May; 37(5):6599-606. PubMed ID: 26643892
[TBL] [Abstract][Full Text] [Related]
39. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B inactive carriers: clinical course and outcomes.
Tong MJ; Trieu J
J Dig Dis; 2013 Jun; 14(6):311-7. PubMed ID: 23433008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
